Spindletop Health Acquisition Corp. (SHCA) is a blank check company with no significant operations that intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses focused on the healthcare services industry sector, including healthcare services, healthcare information technology, insurance and related products, biotechnology, pharmaceuticals, medical devices and diagnostics. Incorporated in 2021 and headquartered in Austin, Texas, the company raised $230 million in its initial public offering on November 4, 2021, through 23 million units at $10 each, led by Barclays, with CEO Evan S. Melrose, M.D., MBA, and Chairman James Henry. In December 2022, following the failure to complete an initial business combination by its termination date of December 20 despite a stockholder-approved extension, Spindletop announced its liquidation and dissolution, redeeming all outstanding public shares by December 27, 2022, after which it ceased operations and was delisted from Nasdaq.